Friday, March 29, 2024

Tag: Geron Corp

Where Does Geron’s Exit from Embryonic Stem Cells Leave the Field?

Given that the firm with the most money has just quit, questions about how to succeed are rampant. Geron, a pioneer in stem cell research...

Funding derails stem cell program aimed at paralytic

For patients paralyzed by spinal cord injuries, Geron Corp.'s stem cell research was the shining hope. The biotech firm showered scientists with millions of dollars...

Stanford team treats final patient in landmark stem cell therapy trial

(Medical Xpress) -- The Stanford University School of Medicine and Santa Clara Valley Medical Center treated the fifth patient in the Geron Corp-sponsored trial...

Preliminary Human Experiments to Test Safety of Nerve Cell Transplants for Spinal Cord Paralysis

The new approach, currently being studied by the FDA for phase I trials, avoids the problems of immunological rejection and the controversy around the...